Overview

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The investigators intend to show that DDAVP improves platelet activity from baseline to 60 minutes after treatment start.
Phase:
Phase 2
Details
Lead Sponsor:
Northwestern University
Collaborator:
Northwestern Memorial Hospital
Treatments:
Deamino Arginine Vasopressin